PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$290.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
28 November 2023
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.

This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.

Edited by:   , , , , , , , , , , , , , ,
Imprint:   Academic Press Inc
Country of Publication:   United Kingdom
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   450g
ISBN:   9780323951142
ISBN 10:   0323951147
Pages:   600
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1. SKIN CANCER BIOLOGY AND ITS BIOMARKERS:RECENT TRENDS AND PROSPECTIVE Himani Sharma 2. ROLE OF BIOMARKERS IN ASSESSING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER TREATMENT Shyam Aggarwal 3. GENOTYPE INFLUENCED PHARMACOKINETICS OF ANTI-CANCER MEDICINE: A CONNECTING LINK Shamsher Singh 4. GENETIC PREDISPOSITION AND PATHOPHYSIOLOGY OF ORAL SQUAMOUS CELL CARCINOMA Gowtham Kumar Subbaraj 5. ORAL SQUAMOUS CELL CARCINOMA Anubha Gulati 6. SHARED AND DISTINCT ASPECTS OF HEMATOPOIETIC MALIGNANCIES SUCH AS LEUKEMIA AND LYMPHOMA Ramakrishnan Veerabathiran 7. MOLECULAR DIAGNOSIS, DRIVERS AND TREATMENT LYMPHOCYTIC LEUKEMIA Saurabh Yadav 8. MYELODYSPLASTIC SYNDROME – A CHALLENGING ENTITY Anshu Palta 9. MULTIPLE MYELOMA Vijay Goni 10. MOLECULAR BIOMARKERS IN PROSTATE CANCER KATSUNORI UCHIDA and Remi Semba 11. GENETICS OF NEURONAL AND GLIONEURONAL CANCERS Anshika Srivastava 12. RECENT ADVANCEMENT IN MOLECULAR MARKER OF PANCREATIC CANCER Kanagaraj Palaniyandi 13. MOLECULAR BIOMARKERS IN GASTRIC CANCER Yoshifumi S. Hirokawa and Kazuki Kanayama 14. MOLECULAR BIOMARKERS IN PANCREATIC DUCTAL ADENOCARCINOMA Yoshifumi S. Hirokawa, Reiko Yamada and Junya Tsuboi 15. BIOMARKERS IN ENDOMTRIAL AND CERVICAL CANCER Aashima Arora 16. BIOMARKERS IN ENDOCRINE DISEASES Sunil Chumber and Dhritiman Maitra 17. CANCER IMMUNOTHERAPY ASSOCIATED ENDOCRINE COMPLICATIONS Kousik Pramanick 18. THERAPEUTIC POTENTIAL OF MELATONIN IN GLIOBLASTOMA: CURRENT KNOWLEDGE AND FUTURE PROSPECTS Nithar Ranjan Madhu Sr. 19. ANTICANCER ACTIVITIES OF MACROMOLECULES OFMARINE ORIGIN: CLINICAL EVIDENCE Maushmi Shailesh Kumar 20. NANOPARTICLES AS A MEANS OF DRUG DELIVERY IN CANCER THERAPY Olorunfemi Raphael Molehin 21. THERAPEUTIC POTENTIAL OF MICROALGAE AND THEIR PROSPECTS IN TARGETED DELIVERY IN CANCER MANAGEMENT Maushami Kumar and Maushmi Shailesh Kumar 22. PROSPECTS OF MANGROVE DERIVED PHYTOCHEMICALS IN CANCER RESEARCH Punarbasu Choawdhury 23. PHYTOCHEMICALS AND MIRNA BASED THERAPEUTIC OPPORTUNITIES FOR CANCER STEM CELL MEDIATED TUMOR ANGIOGENESIS Anandan Balakrishnan 24. EMERGENCE OF METAL-BASED ANTICANCER THERAPEUTICS: A PROMISING PERSPECTIVE Suman Adhikari 25. NEW INFRARED (NIR) RESPONSE NANOMATERIAL LIPOSOME NANOHYBRID FOR CANCER PHOTO THERMAL Animesh Pan 26. IMPACT OF PESTICIDES ON IMMUNE-ENDOCRINE DISORDERS AND ITS RELATIONSHIP TO CANCER DEVELOPMENT Carolina Panis

Professor Sobti is an Education Consultant Governor of Bihar and Senior Scientist at the Indian National Science Academy, in addition to Former Vice Chancellor at Babasaheb Bhimrao Ambedkar University, Lucknow, and Panjab University, Chandigarh, India. Beginning his career as a Cytogeneticist, Professor Sobti moved on to explore the role of gene polymorphisms and their expression in the genesis of various cancers, COPD, AIDS and metabolic syndrome. He has identified disease susceptible / protective novel genotypes and determined the crucial role of SACS-1 and STAT genes in the genesis of cervical and prostate cancers. He has contributed to 270 research publications, 35 books and 23 sponsored research projects. He has received prestigious awards and medals, including the honor of “Padma Shri” from the Government of India for his contribution to higher education. Additionally he was honored with ‘Bharat Gaurav’, Lifetime Achievement Award at the House of Commons, British Parliament, London, UK. Dr.Watanabe graduated from Yokohama National University, Faculty of Engineering (1983), and Mie University, Faculty of Medicine (1989). He obtained a doctor in Medicine from Mie University (1993). He was a professor at Graduate School of Engineering, Yokohama national University (2003-2017), and also a guest professor at School of Medicine, Yokohama City University (2011-1017). He was a visiting fellow in NIH/NIEHS (1997-1999, Dr. J. Carl Barrett). He is now a professor, at School of Medicine, Mir University (2017-). He has published more than 130 scientific publications. He is a member and councilor in Japanese Society of Pathology, and in Japanese Cancer Association. Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology.

See Also